Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic...

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Oncology

Background:

• Topoisomerase 1 (Top1) inhibitors are crucial for treating refractory tumors, yet their binding site and activity-driving ligand properties remain poorly understood.
• Developing new Top1 agents is of significant interest, necessitating a deeper understanding of structure-activity relationships.

Purpose of the Study:

• To establish a quantitative structure-activity relationship (QSAR) model for camptothecins (CPTs) using National Cancer Institute (NCI) drug databases.
• To identify molecular descriptors correlating with antitumor activity for improved drug design.

Main Methods:

• Utilized hierarchical clustering to analyze antitumor activity patterns of 167 CPTs from the NCI drug database.
• Applied various statistical methods, including genetic function approximation (GFA), to build QSAR models.
• Identified key molecular descriptors, including partial atomic charges and specific interatomic distances, correlated with antitumor activity.

Main Results:

• Observed coherence between CPT chemical structures and their antitumor activity patterns (average Pearson correlation coefficient of 0.70).
• The GFA method demonstrated superior performance in correlation and cross-validation compared to other statistical approaches.
• A predictive QSAR model was developed with a cross-validated r² of 0.783.

Conclusions:

• The developed QSAR model provides valuable insights into the structural determinants of Top1 inhibitor activity.
• This approach aids in understanding drug action and resistance mechanisms.
• The identified molecular descriptors can guide the rational design of novel and more effective Top1-based anticancer drugs.